Williams Tryon M

KDOZF Chairman Tryon buys 2,000 shares at $0.23; adds to 4 consecutive-day purchase pattern amid -10.9% 90-day decline and unprofitable fundamentals.

Williams Tryon M, Chairman of KIDOZ INC., purchased 2,000 shares at $0.23 on 2026-03-10, the fifth consecutive day of open-market buying at this ticker. His prior same-ticker purchase from 2025-05-30 resulted in a 90d return of -28.3%, and no prior buy at KDOZF has produced a positive 90-day outcome yet. The stock trades 25.8% below its 52-week high and down 10.9% over the past 90 days, while the company remains unprofitable (net income $-313.8K in the latest quarter) despite 74.5% annual revenue growth. The repeated acquisition pattern over four days suggests a sustained accumulation rather than a single tactical move, warranting monitoring for timing effectiveness against the company's negative profitability backdrop.

Chairman Williams Tryon M purchased 2,000 shares of KIDOZ INC. (KDOZF) at $0.23 on 2026-03-09, expanding position to 16.62M shares in unprofitable micro-cap.

Williams Tryon M, Chairman of KIDOZ INC., acquired 2,000 shares at $0.23 on 2026-03-09, bringing his holdings to 16,620,566 shares. The stock currently trades at $0.23, down 25.8% from its 52-week high of $0.31 and down 3.8% over the past 30 days. This represents his fourth buy at KDOZF in the past week (purchases on 2026-03-10, 2026-03-06, 2026-03-04, and 2026-03-03), suggesting sustained acquisition activity. His prior KDOZF buy on 2025-05-30 returned -28.3% at the 90-day mark, indicating poor timing on that occasion. KIDOZ remains unprofitable with an annual net income of $-313,774.00 despite 74.5% revenue growth, and the company has minimal earnings multiple (P/E: 0.00) with a $30.2M market cap. The concentrated pattern of buys into a declining stock within a small, unprofitable company warrants investor attention to the company's turnaround prospects and the sustainability of the insider's conviction.

Chairman Tryon bought 8,000 shares of KDOZF at $0.23; stock down -25.8% from 52-week high. Persistent underperformance at this ticker.

Williams Tryon M, Chairman of KIDOZ INC., purchased 8,000 shares at $0.23 on 2026-03-06, increasing his holdings to 16,618,566 shares. The stock is currently trading 25.8% below its 52-week high of $0.31 and has declined 21.4% over the past 30 days. Notably, this is Tryon's third purchase in three days (preceded by buys on 2026-03-04 and 2026-03-03), suggesting accumulation activity during a period of price weakness. However, his prior trades at KDOZF show a poor track record: of 3 prior completed buys at this ticker, none were well-timed at the 90-day mark, with returns ranging from -28.3% to -22.2% on two older positions. The company remains unprofitable (full-year net income was negative) despite strong annual revenue growth of 74.5%, presenting a speculative profile where timing and momentum matter considerably for shareholder returns.

Chairman Williams buys 2,000 shares of KDOZF at $0.22; stock now $0.24, unprofitable with -22.6% 30d decline

Chairman Williams Tryon M purchased 2,000 shares at $0.22 on 2026-03-04, adding minimally to holdings of 16.61M shares. The stock has declined 22.6% over the prior 30 days and trades 22.6% below its 52-week high of $0.31. His prior buys at KDOZF show a weak record: 0 of 4 measurable prior trades achieved positive 90-day returns, with outcomes ranging from -28.3% to +29.9%. The company is unprofitable with full-year net income of $-313,774.00, though annual revenue growth was +74.5%. This purchase arrives after a sharp recent price decline, but the chairman's historical execution at this ticker—a 0% win rate at the 90-day mark—offers no reassurance of improved timing.

Chairman Williams buys 5,000 shares of KIDOZ (KDOZF) at $0.25; stock now $0.24, down 22.6% in 30 days.

Chairman Tryon Williams purchased 5,000 shares at $0.25 on March 3, 2026, expanding his holdings from 16.60M to 16.61M shares. The timing is notable: Williams has made 5 prior purchases of KDOZF, and only 1 of those 5 prior buys achieved positive 90-day returns, suggesting a poor track record of entry timing at this ticker. The current price of $0.24 sits 22.6% below the 52-week high and matches the 30-day decline precisely, indicating the stock has weakened significantly since this purchase. While Williams' cross-ticker buy track record shows a 55.56% 90-day win rate and +33.1% average 90-day return, his KDOZF-specific history shows the opposite pattern: 4 of 5 prior buys declined over the 90-day period after entry. KDOZF remains unprofitable despite 74.5% annual revenue growth, with the company posting negative net income of -$313.8K in the latest quarter. This buy adds to a pattern of accumulation at a ticker where entry timing has historically lagged the stock's subsequent movements.

Williams Tryon M (Chairman) purchases 15,750 shares of KIDOZ at $0.22; latest of 5 buys in 60 days despite unprofitability

Williams Tryon M's purchase of 15,750 shares at $0.22 on 2025-05-30 marks the chairman's fifth open-market buy of KIDOZ stock within approximately two months (prior buys on 2025-04-29, 2025-04-28, 2025-04-25, 2025-03-03, and 2025-02-28). His prior same-ticker trades show mixed near-term outcomes: three recent April purchases each realized 30-day returns around +13.9% to +29.9%, though one March purchase suffered a -25.1% 30-day loss, and the February purchase eventually recovered to +73.3% at the 90-day mark. The company operates at a loss (net income $-313.8K in the latest quarter) despite strong revenue growth of +74.5% year-over-year, and trades at a current price $0.22 that is -26.7% from its 52-week high of $0.30. The accumulation pattern over two months at a currently depressed price level—combined with the chairman's demonstrated cross-ticker track record (8 prior buys, 90d win rate 100.00%)—suggests conviction in the underlying business trajectory despite current unprofitability, but this conviction remains unproven at the ticker-specific level where measurable 90-day outcomes exist for only one prior trade.

Chairman Williams Tryon M bought 5,000 shares of KDOZF at $0.23 on 2025-04-29; stock currently $0.21, -34.4% from 52-week high

Williams Tryon M purchased 5,000 shares at $0.23, increasing his holdings from 16,582,816 to 16,587,816 shares, a modest increment to an already substantial position. The stock has declined -34.4% from its 52-week high of $0.32 and currently trades at $0.21, below the purchase price. His prior trades at KDOZF show mixed near-term outcomes: a March purchase declined -25.1% over 30 days, while a December 2024 purchase achieved a +130.9% gain over 90 days, representing 1 of 1 measurable long-term outcomes that were well-timed. The company reported revenue of $3.5M with a net loss of -$313.8K in its latest quarter and remains unprofitable on a full-year basis, though it showed +74.5% annual revenue growth.

Chairman Tryon buys 5,000 shares of KDOZF at $0.23; stock now $0.22, continuing pattern of 5 purchases in 5 months amid strong revenue growth but ongoing losses.

Williams Tryon M, the Chairman, purchased 5,000 shares at $0.23 on 2025-04-28, just three days after buying 5,000 shares at the same ticker on 2025-04-25. This transaction extends a pattern of frequent accumulation: Tryon has executed 5 prior trades at KDOZF since late November 2024. The company has posted strong fundamentals signals—annual revenue growth of +74.5% and recent quarterly revenue of $3.5M—but remains unprofitable, with net income of $-313.8K over its most recent full fiscal year. At his same-ticker history, 2 of 2 prior trades with measurable 90-day outcomes were well-timed, posting +130.9% and +69.9% returns. The stock has rebounded +33.3% over the past 30 days and +60.4% over the past 90 days from its lows, though it now trades at $0.22—31.2% below its 52-week high. The rapid succession of small purchases over five months, paired with the company's revenue momentum and the insider's demonstrated accuracy at this ticker on prior buys, suggests sustained conviction despite persistent unprofitability and recent price decline.

Chairman Williams Tryon M bought 15,000 shares at $0.22; maintains 16.58M shares post-transaction.

Williams Tryon M, as Chairman, purchased 15,000 shares of KIDOZ INC. at $0.22 on 2025-04-25, accumulating to 16,577,816 shares. This is his fifth consecutive buy at this ticker over a five-month window (Nov 2024–Apr 2025), with all three prior measurable 90-day outcomes positive: +112.4%, +69.9%, and +130.9% respectively. His cross-ticker track record shows a 100% 90-day win rate across 5 prior buys with an average 90-day return of +104.4%. However, the current stock is trading at $0.23, down 28.1% from the 52-week high of $0.32, and the company remains unprofitable with negative net income of $-313,774.00 over its most recent full fiscal year despite revenue growth of +74.5%. The repeated accumulation at low absolute prices by a controlling shareholder in a micro-cap, loss-making company signals continued conviction, though the fundamental profitability deficit and distance from the 52-week peak warrant careful evaluation of execution risk.

Chairman buys 15,000 shares across 2 purchases (Feb–Mar 2025) at blended $0.18; 3 prior KDOZF buys all returned +69.9% to +130.9% within 90 days

Williams Tryon M, Chairman of KIDOZ INC., made 2 purchases totaling 15,000 shares for $2,766.00 between February 28 and March 3, 2025, at prices ranging from $0.17 to $0.21. His same-ticker history shows a consistent pattern of well-timed entries: all 3 prior buys at KDOZF generated positive 90-day returns (+130.9%, +69.9%, and +112.4%), with the most recent prior buy (Dec 3, 2024) showing 90-day gains of +130.9%. The current price of $0.23 sits at -28.1% from the 52-week high but has surged +666.7% over the past 30 days and +130.0% over 90 days, indicating a recent sharp recovery from depressed levels. The company remains unprofitable (net income $-313,774.00) but posted strong annual revenue growth of +74.5%, suggesting operational improvement despite near-term losses. The Chairman's repeat accumulation pattern at this ticker, combined with his 100% win rate on same-ticker buys at the 90-day mark, suggests confidence in a recovery trajectory already in progress.